MONTANARO, NICOLA
MONTANARO, NICOLA
DIP. DI FARMACOLOGIA
A 3 year survey on the use of antibacterial agents in five Italian hospitals.
2008-01-01 Vaccheri A; Silvani MC; Bersaglia L; Motola D; Strahinja P; Vargiu A; Poluzzi E; Montanaro N.
A 5 years surveillance of antibiotic use and microbiological resistance in an Italian university hospital.
2009-01-01 Silvani M.C.; Poluzzi E.; Motola D.; Quaranta P.; Nanetti A.; Ambretti S.; Fiacchi P.; Puggioli C.; Vaccheri A.; Montanaro N.
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage
2007-01-01 Poluzzi E.; Strahinja P.; Vaccheri A.; Vargiu A.; Silvani M.C.; Motola D.; Marchesini G.; De Ponti F.; Montanaro N.
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage.
2006-01-01 Poluzzi E; Strahinja P; Vargiu A; Silvani MC; Motola D; Vaccheri A; De Ponti F; Marchesini Reggiani G; Montanaro N.
Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy
2008-01-01 Poluzzi E; Strahinja P; Lanzoni M; Vargiu A; Silvani MC; Motola D; Gaddi A; Vaccheri A; Montanaro N.
An approach to evaluate appropriateness in the antibacterial therapy in Italian hospitals.
2007-01-01 Silvani MC; Bersaglia L; Poluzzi E; Motola D; Bottoni A; Strahinja P; Vargiu A; Vaccheri A; Montanaro N.
Analyses of natalizumab prescriptions and discontinuations in multiple sclerosis patients of an Italian region
2011-01-01 Sacripanti C; Piccinni C; Puccini A; Poluzzi E; Montanaro N
Antibiotic Use and Microbiological Surveillance: An Ecological Study in an Italian University Hospital.
2008-01-01 M. C. Silvani; L. Bersaglia; E. Poluzzi; D. Motola; A. Nanetti; S. Ambretti; A. Bottoni; A. Vaccheri; N. Montanaro.
Antibiotic use in Italian hospitals 2002-2004.
2006-01-01 Silvani MC; Poluzzi E; Motola D; Strahinja P; Vargiu A; Bersaglia L; Vaccheri A; Montanaro N.
Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures
2011-01-01 Lapi F.; Sessa E.; Di Bari M.; Corrao G.; Zambon A.; Scotti L.; Sturkenboom M.; Geppetti P.; Gregori D.; Carle F.; Menna A.; Vestri A.R.; Vaccheri A.; Piccinni C.; Puccini A.; Montanaro N.; Caputi A.P.; Mazzaglia G.
Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to Bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures,
2011-01-01 Lapi F.; Sessa E.; Di Bari M.; Corrao G.; Zambon A.; Scotti L.; Sturkenboom M.; Geppetti .P; Gregori D.; Carle F.; Menna A.; Vestri A.R.; Vaccheri A.; Piccinni C.; Puccini A.; Montanaro N.; Arcoraci V.; Caputi A.P.; Mazzaglia G.
Le basi della farmacologia
2007-01-01 Montanaro N.; Motola D.; Vaccheri A.
Cardiovascular events in statin recipients: a 3-year record-linkage study on prescription and hospital discharge databases
2010-01-01 Poluzzi E.; Piccinni C.; Carta P.; Puccini A.; Lanzoni M.; Motola D.; Vaccheri A. ; De Ponti F.; Montanaro N.
Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study
2011-01-01 Poluzzi E.; Piccinni C.; Carta P.; Puccini A.; Lanzoni M.; Motola D.; Vaccheri A.; De Ponti F.; Montanaro N.
Changes in prevalence and pattern of drug use in a ten years period in Italy. 8th Congress of the European Association for Clinical Pharmacology and Therapeutics
2007-01-01 Silvani MC; Motola D; Poluzzi E; Strahinja P; Vargiu A; Biagi C; Vaccheri A; Montanaro N.
Un commento alla lettera sulla definizione di farmaco innovativo
2012-01-01 Motola D.; Montanaro N.
Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions
2014-01-01 C. Biagi;V. Conti;N. Montanaro;M. Melis;E. Buccellato;M. Donati;A. Covezzoli;R. Amato;L. Pazzi;M. Venegoni;A. Vaccheri;D. Motola
Developing a Method To Identify Prescribing Profiles of Antihypertensive Drugs in General Practice.
2004-01-01 Voci C; Sangiorgi Cellini G; Silvani C; Poluzzi E; Vargiu A; Vaccheri A; Montanaro N.
Dronedarone-associated acute renal failure: evidence coming from the Italian spontaneous ADR reporting database
2013-01-01 Chiara Biagi;Mauro Venegoni;Mauro Melis;Elena Buccellato;Nicola Montanaro;Domenico Motola
Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database.
2005-01-01 Leone R.; Conforti A.; Venegoni M.; Motola D.; Moretti U.; Meneghelli I.; Cocci A.; Sangiorgi Cellini G.; Scotto S.; Montanaro N.; Velo G.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| A 3 year survey on the use of antibacterial agents in five Italian hospitals. | Vaccheri A; Silvani MC; Bersaglia L; Motola D; Strahinja P; Vargiu A; Poluzzi E; Montanaro N. | 2008-01-01 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | - | 1.01 Articolo in rivista | - |
| A 5 years surveillance of antibiotic use and microbiological resistance in an Italian university hospital. | Silvani M.C.; Poluzzi E.; Motola D.; Quaranta P.; Nanetti A.; Ambretti S.; Fiacchi P.; Puggioli C....; Vaccheri A.; Montanaro N. | 2009-01-01 | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | - | 4.02 Riassunto (Abstract) | - |
| Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage | Poluzzi E.; Strahinja P.; Vaccheri A.; Vargiu A.; Silvani M.C.; Motola D.; Marchesini G.; De Pont...i F.; Montanaro N. | 2007-01-01 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. | Poluzzi E; Strahinja P; Vargiu A; Silvani MC; Motola D; Vaccheri A; De Ponti F; Marchesini Reggia...ni G; Montanaro N. | 2006-01-01 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | - | 4.02 Riassunto (Abstract) | - |
| Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy | Poluzzi E; Strahinja P; Lanzoni M; Vargiu A; Silvani MC; Motola D; Gaddi A; Vaccheri A; Montanaro N. | 2008-01-01 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| An approach to evaluate appropriateness in the antibacterial therapy in Italian hospitals. | Silvani MC; Bersaglia L; Poluzzi E; Motola D; Bottoni A; Strahinja P; Vargiu A; Vaccheri A; Monta...naro N. | 2007-01-01 | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | - | 4.02 Riassunto (Abstract) | - |
| Analyses of natalizumab prescriptions and discontinuations in multiple sclerosis patients of an Italian region | Sacripanti C; Piccinni C; Puccini A; Poluzzi E; Montanaro N | 2011-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Antibiotic Use and Microbiological Surveillance: An Ecological Study in an Italian University Hospital. | M. C. Silvani; L. Bersaglia; E. Poluzzi; D. Motola; A. Nanetti; S. Ambretti; A. Bottoni; A. Vacch...eri; N. Montanaro. | 2008-01-01 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | - | 4.02 Riassunto (Abstract) | - |
| Antibiotic use in Italian hospitals 2002-2004. | Silvani MC; Poluzzi E; Motola D; Strahinja P; Vargiu A; Bersaglia L; Vaccheri A; Montanaro N. | 2006-01-01 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | - | 4.02 Riassunto (Abstract) | - |
| Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures | Lapi F.; Sessa E.; Di Bari M.; Corrao G.; Zambon A.; Scotti L.; Sturkenboom M.; Geppetti P.; Greg...ori D.; Carle F.; Menna A.; Vestri A.R.; Vaccheri A.; Piccinni C.; Puccini A.; Montanaro N.; Caputi A.P.; Mazzaglia G. | 2011-01-01 | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | Wiley Blackewell | 4.02 Riassunto (Abstract) | - |
| Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to Bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures, | Lapi F.; Sessa E.; Di Bari M.; Corrao G.; Zambon A.; Scotti L.; Sturkenboom M.; Geppetti .P; Greg...ori D.; Carle F.; Menna A.; Vestri A.R.; Vaccheri A.; Piccinni C.; Puccini A.; Montanaro N.; Arcoraci V.; Caputi A.P.; Mazzaglia G. | 2011-01-01 | - | Società Italiana di Farmacologia | 4.02 Riassunto (Abstract) | - |
| Le basi della farmacologia | Montanaro N.; Motola D.; Vaccheri A. | 2007-01-01 | - | Zanichelli | 5.01 Libro (Traduzione) | - |
| Cardiovascular events in statin recipients: a 3-year record-linkage study on prescription and hospital discharge databases | Poluzzi E.; Piccinni C.; Carta P.; Puccini A.; Lanzoni M.; Motola D.; Vaccheri A. ; De Ponti F.; ...Montanaro N. | 2010-01-01 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | Wiley Blackewell | 4.02 Riassunto (Abstract) | - |
| Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study | Poluzzi E.; Piccinni C.; Carta P.; Puccini A.; Lanzoni M.; Motola D.; Vaccheri A.; De Ponti F.; M...ontanaro N. | 2011-01-01 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Changes in prevalence and pattern of drug use in a ten years period in Italy. 8th Congress of the European Association for Clinical Pharmacology and Therapeutics | Silvani MC; Motola D; Poluzzi E; Strahinja P; Vargiu A; Biagi C; Vaccheri A; Montanaro N. | 2007-01-01 | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | - | 4.02 Riassunto (Abstract) | - |
| Un commento alla lettera sulla definizione di farmaco innovativo | Motola D.; Montanaro N. | 2012-01-01 | PHARMACOECONOMICS, ITALIAN RESEARCH ARTICLES | - | 1.01 Articolo in rivista | - |
| Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions | C. Biagi;V. Conti;N. Montanaro;M. Melis;E. Buccellato;M. Donati;A. Covezzoli;R. Amato;L. Pazzi;M.... Venegoni;A. Vaccheri;D. Motola | 2014-01-01 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Developing a Method To Identify Prescribing Profiles of Antihypertensive Drugs in General Practice. | Voci C; Sangiorgi Cellini G; Silvani C; Poluzzi E; Vargiu A; Vaccheri A; Montanaro N. | 2004-01-01 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | - | 4.02 Riassunto (Abstract) | - |
| Dronedarone-associated acute renal failure: evidence coming from the Italian spontaneous ADR reporting database | Chiara Biagi;Mauro Venegoni;Mauro Melis;Elena Buccellato;Nicola Montanaro;Domenico Motola | 2013-01-01 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database. | Leone R.; Conforti A.; Venegoni M.; Motola D.; Moretti U.; Meneghelli I.; Cocci A.; Sangiorgi Cel...lini G.; Scotto S.; Montanaro N.; Velo G. | 2005-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | - |